Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

References for PMC Articles for PubMed (Select 22540892)

1.

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.

Chauhan VP, Stylianopoulos T, Martin JD, Popović Z, Chen O, Kamoun WS, Bawendi MG, Fukumura D, Jain RK.

Nat Nanotechnol. 2012 Apr 8;7(6):383-8. doi: 10.1038/nnano.2012.45.

2.

Amyloid-derived peptide forms self-assembled monolayers on gold nanoparticle with a curvature-dependent β-sheet structure.

Shaw CP, Middleton DA, Volk M, Lévy R.

ACS Nano. 2012 Feb 28;6(2):1416-26. doi: 10.1021/nn204214x. Epub 2012 Jan 20.

PMID:
22242947
3.

Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration.

Chauhan VP, Popović Z, Chen O, Cui J, Fukumura D, Bawendi MG, Jain RK.

Angew Chem Int Ed Engl. 2011 Nov 25;50(48):11417-20. doi: 10.1002/anie.201104449. Epub 2011 Oct 6. No abstract available.

4.

Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment.

Kumar A, Ma H, Zhang X, Huang K, Jin S, Liu J, Wei T, Cao W, Zou G, Liang XJ.

Biomaterials. 2012 Feb;33(4):1180-9. doi: 10.1016/j.biomaterials.2011.10.058. Epub 2011 Nov 5.

PMID:
22056754
5.

Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population.

Kim JA, Åberg C, Salvati A, Dawson KA.

Nat Nanotechnol. 2011 Nov 6;7(1):62-8. doi: 10.1038/nnano.2011.191.

PMID:
22056728
6.

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.

Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M, Nishiyama N, Kataoka K.

Nat Nanotechnol. 2011 Oct 23;6(12):815-23. doi: 10.1038/nnano.2011.166.

PMID:
22020122
7.

Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.

Goldsborough AS, Handley MD, Dulcey AE, Pluchino KM, Kannan P, Brimacombe KR, Hall MD, Griffiths G, Gottesman MM.

J Med Chem. 2011 Jul 28;54(14):4987-97. doi: 10.1021/jm2001663. Epub 2011 Jun 24.

8.

The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles.

Cho EC, Zhang Q, Xia Y.

Nat Nanotechnol. 2011 Apr 24;6(6):385-91. doi: 10.1038/nnano.2011.58.

9.

Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.

Wang F, Wang YC, Dou S, Xiong MH, Sun TM, Wang J.

ACS Nano. 2011 May 24;5(5):3679-92. doi: 10.1021/nn200007z. Epub 2011 Apr 12.

PMID:
21462992
10.

Multistage nanoparticle delivery system for deep penetration into tumor tissue.

Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan VP, Jiang W, Popovic Z, Jain RK, Bawendi MG, Fukumura D.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2426-31. doi: 10.1073/pnas.1018382108. Epub 2011 Jan 18. Erratum in: Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6336.

11.

Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration.

Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG.

Eur J Pharm Biopharm. 2011 Apr;77(3):407-16. doi: 10.1016/j.ejpb.2010.12.029. Epub 2010 Dec 31.

12.

Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors.

Maus L, Dick O, Bading H, Spatz JP, Fiammengo R.

ACS Nano. 2010 Nov 23;4(11):6617-28. doi: 10.1021/nn101867w. Epub 2010 Oct 12.

PMID:
20939520
13.

Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.

Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L.

Clin Cancer Res. 2010 Dec 15;16(24):6139-49. doi: 10.1158/1078-0432.CCR-10-0978. Epub 2010 Sep 27.

14.

Cellular response of polyvalent oligonucleotide-gold nanoparticle conjugates.

Massich MD, Giljohann DA, Schmucker AL, Patel PC, Mirkin CA.

ACS Nano. 2010 Oct 26;4(10):5641-6. doi: 10.1021/nn102228s.

15.

Gold nanostructures: a class of multifunctional materials for biomedical applications.

Cobley CM, Chen J, Cho EC, Wang LV, Xia Y.

Chem Soc Rev. 2011 Jan;40(1):44-56. doi: 10.1039/b821763g. Epub 2010 Sep 6. Review.

PMID:
20818451
16.

Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria.

Zhao Y, Tian Y, Cui Y, Liu W, Ma W, Jiang X.

J Am Chem Soc. 2010 Sep 8;132(35):12349-56. doi: 10.1021/ja1028843.

PMID:
20707350
17.

Gold nanoparticle platforms as drug and biomacromolecule delivery systems.

Duncan B, Kim C, Rotello VM.

J Control Release. 2010 Nov 20;148(1):122-7. doi: 10.1016/j.jconrel.2010.06.004. Epub 2010 Jun 11. Review.

18.

Tuning payload delivery in tumour cylindroids using gold nanoparticles.

Kim B, Han G, Toley BJ, Kim CK, Rotello VM, Forbes NS.

Nat Nanotechnol. 2010 Jun;5(6):465-72. doi: 10.1038/nnano.2010.58. Epub 2010 Apr 11.

19.

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

He C, Hu Y, Yin L, Tang C, Yin C.

Biomaterials. 2010 May;31(13):3657-66. doi: 10.1016/j.biomaterials.2010.01.065. Epub 2010 Feb 6.

PMID:
20138662
20.

The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells.

Cho EC, Au L, Zhang Q, Xia Y.

Small. 2010 Feb 22;6(4):517-22. doi: 10.1002/smll.200901622. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk